# Harvard Bioscience Inc: Form 8-K, filed Jun 23, 2025

- Company: [Harvard Bioscience Inc](/companies/hbio.md) (CIK 1123494)
- Form: 8-K
- Filed: 2025-06-23
- Accepted by EDGAR: Jun 23, 2025, 16:46 ET
- Period: 2025-06-18
- Accession: 0001171843-25-004036
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1123494/000117184325004036/f8k_062325.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1123494/000117184325004036/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1123494/000117184325004036/f8k_062325.htm

Filed Jun 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-004036. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.